Literature DB >> 25437112

Quantitative analysis of drug losses administered via nasogastric tube--In vitro study.

Adriana Ruzsíková1, Lenka Součková2, Pavel Suk2, Radka Opatřilová3, Martina Kejdušová3, Vladimír Šrámek4.   

Abstract

PURPOSE: Drug administration through nasogastric tube (NGT) is a standard practice but the real amount of the delivered drug is unknown. Therefore, we designed a study to determine the losses of various dosage forms administered by different methods through NGT.
METHODS: In vitro model was used. Five different administration methods (A-E) and six dosage forms (simple compressed tablets - T/S; film coated tablets - T/FC; enteric coated tablets - T/EC; capsules with powder filling - C/P; capsules containing extended release pellets - C/ER; capsules containing gastro-resistant pellets - C/GR) were investigated. Measurement was repeated six times for each drug-method combination. The overall losses were determined by gravimetry. In method A partial losses associated with each step of drug administration were also determined.
RESULTS: Significant drug losses were measured (4-38%). Only methods A (crushing-beaker-syringe-water-NGT) and B (crushing-water-syringe-NGT) were suitable for administration of all tested dosage forms. Method B proved the most effective for all kinds of tablets and C/GR (p<0.05) and tended to be more effective also for C/ER (p=0.052) compared to method A. C/P showed minimal losses for both tested methods (B and E). Flushing of the drug through NGT causes major losses during drug administration compared to crushing and transfer (p<0.05). All methods for intact pellets (C-E) were found inappropriate for clinical practice due to NGT clogging.
CONCLUSIONS: Choosing a suitable administration method can significantly affect the amount of drugs delivered through NGT.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dosage forms; Drug administration; Enteral feeding; Intensive care; Nasogastric tube

Mesh:

Substances:

Year:  2014        PMID: 25437112     DOI: 10.1016/j.ijpharm.2014.11.065

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes.

Authors:  Kristin Reindel; Fang Zhao; Susan Hughes; Vivek S Dave
Journal:  Hosp Pharm       Date:  2017-09-25

2.  Potassium canrenoate compounding for administration via enteral feeding tubes: a physical and microbiological stability study.

Authors:  Serena Logrippo; Matteo Sestili; Roberta Ganzetti; Giulia Bonacucina; Antonella Marziali; Patrizia Fattoretti; Silvia Busco; Alessandro Caraffa; Carlo Polidori; Giovanni Filippo Palmieri
Journal:  Eur J Hosp Pharm       Date:  2017-08-05

3.  Technological Evaluation of Emulsions Containing The Volatile Oil from Leaves of Plectranthus Amboinicus Lour.

Authors:  Pablo Queiroz Lopes; Fabíola Bernardo Carneiro; Ana Letícia Braz de Sousa; Sócrates Golziodo Santos; Elquio Eleamen Oliveira; Luiz Alberto Lira Soares
Journal:  Pharmacogn Mag       Date:  2017 Jan-Mar       Impact factor: 1.085

4.  Drug loss while crushing tablets: Comparison of 24 tablet crushing devices.

Authors:  Min Yew Thong; Yady J Manrique; Kathryn J Steadman
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

5.  Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients.

Authors:  D Zanon; U M Musazzi; A Manca; A De Nicolò; A D'Avolio; F Cilurzo; N Maximova; C Tomasello; E Clementi; P Minghetti
Journal:  Data Brief       Date:  2020-10-23

6.  A Safe Way to Administer Drugs Through a Nutrition Tube-The Simple Suspension Method.

Authors:  Kenjiro Kunieda; Naomi Kurata; Yuki Yoshimatsu; Tomohisa Ohno; Takashi Shigematsu; Ichiro Fujishima
Journal:  Dysphagia       Date:  2021-03-14       Impact factor: 3.438

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.